521 related articles for article (PubMed ID: 26792761)
1. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis.
Galling B; Roldán A; Nielsen RE; Nielsen J; Gerhard T; Carbon M; Stubbs B; Vancampfort D; De Hert M; Olfson M; Kahl KG; Martin A; Guo JJ; Lane HY; Sung FC; Liao CH; Arango C; Correll CU
JAMA Psychiatry; 2016 Mar; 73(3):247-59. PubMed ID: 26792761
[TBL] [Abstract][Full Text] [Related]
2. Do antipsychotics increase diabetes risk in children and adolescents?
Galling B; Correll CU
Expert Opin Drug Saf; 2015 Feb; 14(2):219-41. PubMed ID: 25480466
[TBL] [Abstract][Full Text] [Related]
3. Risk of diabetes in children and adolescents exposed to antipsychotics: a nationwide 12-year case-control study.
Nielsen RE; Laursen MF; Vernal DL; Bisgaard C; Jakobsen H; Steinhausen HC; Correll CU
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):971-979.e6. PubMed ID: 25151420
[TBL] [Abstract][Full Text] [Related]
4. Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses.
Cervesi C; Park SY; Galling B; Molteni S; Masi G; Gerhard T; Olfson M; Correll CU
J Clin Psychiatry; 2017 Mar; 78(3):347-357. PubMed ID: 28068462
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.
Bobo WV; Cooper WO; Stein CM; Olfson M; Graham D; Daugherty J; Fuchs DC; Ray WA
JAMA Psychiatry; 2013 Oct; 70(10):1067-75. PubMed ID: 23965896
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.
Nielsen J; Skadhede S; Correll CU
Neuropsychopharmacology; 2010 Aug; 35(9):1997-2004. PubMed ID: 20520598
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.
Gianfrancesco F; Grogg A; Mahmoud R; Wang RH; Meletiche D
Clin Ther; 2003 Apr; 25(4):1150-71. PubMed ID: 12809963
[TBL] [Abstract][Full Text] [Related]
9. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693
[TBL] [Abstract][Full Text] [Related]
10. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
12. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced type 2 diabetes: evidence from a large health plan database.
Gianfrancesco F; White R; Wang RH; Nasrallah HA
J Clin Psychopharmacol; 2003 Aug; 23(4):328-35. PubMed ID: 12920407
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis.
Park SY; Cervesi C; Galling B; Molteni S; Walyzada F; Ameis SH; Gerhard T; Olfson M; Correll CU
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):456-468.e4. PubMed ID: 27238064
[TBL] [Abstract][Full Text] [Related]
15. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.
Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR
JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety of antipsychotics: another look at the risk of diabetes.
Moisan J; Turgeon M; Desjardins O; Grégoire JP
Can J Psychiatry; 2013 Apr; 58(4):218-24. PubMed ID: 23547645
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
